The Latest Breaking News from Pfizer

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to…

A new study from the Center for Disease Control and Prevention confirms what Mayo Clinic and other experts have been saying: COVID-19 booster vaccinations improve protection against severe illness and hospitalization. The study examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether…

Pfizer-BioNTech seeks US approval for under-5s Covid inoculation; Lithuania to scrap Covid pass on Saturday

So far, Pfizer’s vaccine has only been available to people at least five years old

Hospitalizations of children under 5 have reached their highest levels since the beginning of the pandemic.

Pfizer Inc. and partner BioNTech SE have begun submitting data to U.S. regulators for authorization of their COVID-19 vaccine in children 6 months to 4 years old, according to people familiar with the matter, hastening an effort to get shots to younger kids after the omicron wave caused pediatric infections…

The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension

Experts predict 2022 will be the year COVID stops defining our lives. The virus isn't going away but new treatments and ways of thinking could mark the beginning of the end.

People with allergies are told it is safe to get the jab

Vaccine may be available to youngsters below the age of five from February, if FDA approval is granted

Documents obtained by Newsroom under the Official Information Act reveal the numbers the Government has been trying to keep secret - how much New Zealand paid for its vaccines.